Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone-naloxone for Opioid-Induced Constipation in Spine Surgery
NCT02573922Phase 4Completed
- Sponsor
- Kuopio University Hospital
- Start
- May 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxycodone + naloxone in opioid-induced constipation (OIC) (2 arms), sponsored by Kuopio University Hospital. Primary endpoint: Opioid Induced Constipation at 21 days. Started May 2012; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT02573922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02573922.